Page last updated: 2024-09-03

almotriptan and Light Sensitivity

almotriptan has been researched along with Light Sensitivity in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acuto, G; Allais, G; Benedetto, C; Bussone, G; D'Andrea, G; d'Onofrio, F; Grazzi, L; Manzoni, GC; Moschiano, F; Valguarnera, F	1
Galván, J; Heras, J; Láinez, MJ; Vila, C	1
Cady, R	1

Reviews

1 review(s) available for almotriptan and Light Sensitivity

Article	Year
Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis. Headache, 2002, Volume: 42 Suppl 1 Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials, Phase III as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Photophobia; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines; Vomiting	2002

Article

Year

Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.

Headache, 2002, Volume: 42 Suppl 1

Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials, Phase III as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Photophobia; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines; Vomiting

2002

Trials

2 trial(s) available for almotriptan and Light Sensitivity

Article	Year
Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31 Suppl 1 Topics: Adult; Cross-Over Studies; Disease Progression; Double-Blind Method; Female; Humans; Migraine without Aura; Nausea; Pain Measurement; Photophobia; Premenstrual Syndrome; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vomiting	2010
Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy. European journal of neurology, 2007, Volume: 14, Issue:3 Topics: Acute Disease; Adult; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Female; Humans; Male; Migraine Disorders; Nausea; Patient Satisfaction; Phosphodiesterase Inhibitors; Photophobia; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents	2007

Article

Year

Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31 Suppl 1

Topics: Adult; Cross-Over Studies; Disease Progression; Double-Blind Method; Female; Humans; Migraine without Aura; Nausea; Pain Measurement; Photophobia; Premenstrual Syndrome; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vomiting

2010

Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.

European journal of neurology, 2007, Volume: 14, Issue:3

Topics: Acute Disease; Adult; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Female; Humans; Male; Migraine Disorders; Nausea; Patient Satisfaction; Phosphodiesterase Inhibitors; Photophobia; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vasoconstrictor Agents

2007